Cargando…

Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn’s Disease

The aim of the study was to determine the impact of biological treatment with tumor necrosis factor α antibodies (anti-TNF-α) on the intestinal microbiome of children with severe Crohn’s disease (CD) and to evaluate the differences in the intestinal microbiome between patients treated with biologica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kowalska-Duplaga, Kinga, Kapusta, Przemysław, Gosiewski, Tomasz, Sroka-Oleksiak, Agnieszka, Ludwig-Słomczyńska, Agnieszka H., Wołkow, Paweł P., Fyderek, Krzysztof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141282/ https://www.ncbi.nlm.nih.gov/pubmed/32143438 http://dx.doi.org/10.3390/jcm9030687

Ejemplares similares

Differences in the intestinal microbiome of healthy children and patients with newly diagnosed Crohn’s disease
por: Kowalska-Duplaga, Kinga, et al.
Publicado: (2019)

Dependence of Colonization of the Large Intestine by Candida on the Treatment of Crohn’s Disease
por: KOWALSKA-DUPLAGA, KINGA, et al.
Publicado: (2019)

Next-Generation Sequencing as a Tool to Detect Vaginal Microbiota Disturbances during Pregnancy
por: Sroka-Oleksiak, Agnieszka, et al.
Publicado: (2020)

The Gut Microbiota Profile According to Glycemic Control in Type 1 Diabetes Patients Treated with Personal Insulin Pumps
por: Mrozinska, Sandra, et al.
Publicado: (2021)

Association of Fungi and Archaea of the Gut Microbiota with Crohn’s Disease in Pediatric Patients—Pilot Study
por: Krawczyk, Agnieszka, et al.
Publicado: (2021)

Plasma elafin, cathelicidin, and α-defensins are increased in paediatric inflammatory Crohn’s disease and reflect disease location
por: Wędrychowicz, Andrzej, et al.
Publicado: (2021)

Qualitative Parameters of the Colonic Flora in Patients with HNF1A-MODY Are Different from Those Observed in Type 2 Diabetes Mellitus
por: Mrozinska, Sandra, et al.
Publicado: (2016)

Changes in the gut mycobiome in pediatric patients in relation to the clinical activity of Crohn's disease
por: Krawczyk, Agnieszka, et al.
Publicado: (2023)

Changes in Diet and Anthropometric Parameters in Children and Adolescents with Celiac Disease—One Year of Follow-Up
por: Kozioł-Kozakowska, Agnieszka, et al.
Publicado: (2021)

Diagnostic Value of Fecal Calprotectin (S100 A8/A9) Test in Children with Chronic Abdominal Pain
por: Pieczarkowski, Stanisław, et al.
Publicado: (2016)

Metagenomic Analysis of Duodenal Microbiota Reveals a Potential Biomarker of Dysbiosis in the Course of Obesity and Type 2 Diabetes: A Pilot Study
por: Sroka-Oleksiak, Agnieszka, et al.
Publicado: (2020)

Clinical value of serum eosinophilic cationic protein assessment in children with inflammatory bowel disease
por: Wędrychowicz, Andrzej, et al.
Publicado: (2013)

Alterations in intestinal Archaea composition in pediatric patients with Crohn’s disease based on next-generation sequencing – a pilot study
por: Krawczyk, A., et al.
Publicado: (2023)

Duodenal microbiota and weight-loss following sleeve gastrectomy and Roux-en-Y gastric bypass – a pilot study
por: Stefura, Tomasz, et al.
Publicado: (2023)

Comparison of PCR, Fluorescent in Situ Hybridization and Blood Cultures for Detection of Bacteremia in Children and Adolescents During Antibiotic Therapy
por: ŹRÓDŁOWSKI, TOMASZ W., et al.
Publicado: (2018)

Comparison of Antigen Tests and qPCR in Rapid Diagnostics of Infections Caused by SARS-CoV-2 Virus
por: Klajmon, Adrianna, et al.
Publicado: (2021)

Infliximab Therapy Could Decrease the Risk of the Development of Thyroid Disorders in Pediatric Patients With Crohn's Disease
por: Furtak, Aleksandra, et al.
Publicado: (2020)

The transcriptome-wide association search for genes and genetic variants which associate with BMI and gestational weight gain in women with type 1 diabetes
por: Ludwig-Słomczyńska, Agnieszka H., et al.
Publicado: (2021)

Analysis of the Gut Mycobiome in Adult Patients with Type 1 and Type 2 Diabetes Using Next-Generation Sequencing (NGS) with Increased Sensitivity—Pilot Study
por: Salamon, Dominika, et al.
Publicado: (2021)

Mitochondrial GWAS and association of nuclear – mitochondrial epistasis with BMI in T1DM patients
por: Ludwig-Słomczyńska, Agnieszka H., et al.
Publicado: (2020)

Comprehensive detection and identification of bacterial DNA in the blood of patients with sepsis and healthy volunteers using next-generation sequencing method - the observation of DNAemia
por: Gosiewski, T., et al.
Publicado: (2016)

Clinical usefulness of the Mucosal Inflammation Noninvasive Index in newly diagnosed paediatric Crohn’s disease patients
por: Herman, Roma B., et al.
Publicado: (2021)

Variants influencing age at diagnosis of HNF1A-MODY
por: Ludwig-Słomczyńska, Agnieszka H., et al.
Publicado: (2022)

The association of conspiracy beliefs and the uptake of COVID-19 vaccination: a cross-sectional study
por: Kowalska-Duplaga, Kinga, et al.
Publicado: (2023)

Infliximab in the treatment of Crohn’s disease
por: Poggioli, Gilberto, et al.
Publicado: (2007)

A novel, nested, multiplex, real-time PCR for detection of bacteria and fungi in blood
por: Gosiewski, Tomasz, et al.
Publicado: (2014)

Quantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes - a pilot study
por: Gosiewski, Tomasz, et al.
Publicado: (2014)

The Assessment of the Reliability and Validity of the Polish Version of the Adult Vaccine Hesitancy Scale (PL-aVHS) in the Context of Attitudes toward COVID-19 Vaccination
por: Duplaga, Mariusz, et al.
Publicado: (2022)

Dysregulation of Transcription Factor Activity During Formation of Cancer-Associated Fibroblasts
por: Kapusta, Przemysław, et al.
Publicado: (2020)

Comparison of nested, multiplex, qPCR; FISH; SeptiFast and blood culture methods in detection and identification of bacteria and fungi in blood of patients with sepsis
por: Gosiewski, Tomasz, et al.
Publicado: (2014)

Infliximab to treat Crohn’s disease: an update
por: Cottone, M, et al.
Publicado: (2011)

A review of magnetic resonance enterography based Crohn’s disease activity indices in paediatric patients
por: Herman, Roma B., et al.
Publicado: (2022)

Induction of Remission in Pediatric Crohn’s Disease Patients Assessed by the Mucosal Inflammation Noninvasive Index
por: Herman, Roma, et al.
Publicado: (2021)

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
por: Vande Casteele, Niels, et al.
Publicado: (2015)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019)

Early intestinal obstruction after infliximab therapy in Crohn’s disease
por: Chiba, Mitsuro, et al.
Publicado: (2019)

DNA methylation analysis of negative pressure therapy effect in diabetic foot ulcers
por: Ludwig-Slomczynska, A H, et al.
Publicado: (2019)

Do NAAT-Based Methods Increase the Diagnostic Sensitivity of Streptococcus agalactiae Carriage Detection in Pregnant Women?
por: Sroka-Oleksiak, Agnieszka, et al.
Publicado: (2023)

Oral microbiota study of the patients after hospitalisation for COVID-19, considering selected dental indices and antibiotic therapy using the next generation sequencing method (NGS)
por: Brzychczy- Sroka, Barbara, et al.
Publicado: (2023)

Profile of infliximab in the treatment of pediatric Crohn’s disease
por: Kierkus, Jaroslaw, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i1p0u7q1a1u4qofl52v55u6hcg